These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3459563)

  • 21. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia.
    Zaunschirm A; Muntean W
    Pediatr Hematol Oncol; 1986; 3(1):19-25. PubMed ID: 3153215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation changes under L-asparaginase therapy.
    Deutsch E; Fischer M; Frischauf H; Honetz N; Lechner K; Pesendorfer F; Stych H; Weissmann A
    Recent Results Cancer Res; 1970; 33():331-41. PubMed ID: 4262281
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood coagulation disorder due to asparaginase].
    De Rossi G; Conti G; DeLuca AM; Monarca B; Tribalto M
    Haematologica; 1971; 56(9):420-9. PubMed ID: 5004542
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduced antithrombin III levels during L-asparaginase therapy.
    Buchanan GR; Holtkamp CA
    Med Pediatr Oncol; 1980; 8(1):7-14. PubMed ID: 6934369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperglycemia. A complication of chemotherapy in children.
    Walker ED
    Cancer Nurs; 1988 Feb; 11(1):18-22. PubMed ID: 3162821
    [No Abstract]   [Full Text] [Related]  

  • 26. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

  • 27. Antithrombin III deficiency during asparaginase therapy.
    Pitney WR; Phadke KP; Dean S
    Lancet; 1980 Mar; 1(8166):493-4. PubMed ID: 6102228
    [No Abstract]   [Full Text] [Related]  

  • 28. [L-asparaginase, antithrombin III deficiency and thromboses (author's transl)].
    Bordigoni P; Briquel E; Olive D
    Arch Fr Pediatr; 1981 Nov; 38(9):653-5. PubMed ID: 6949499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased antithrombin III concentration in children with acute lymphatic leukaemia receiving L-asparaginase therapy.
    O'Meara A; Daly M; Hallinan FH
    Med Pediatr Oncol; 1988; 16(3):169-74. PubMed ID: 3132590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
    Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
    Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-asparaginase, antithrombin III, and thrombosis.
    Conard J; Cazenave B; Maury J; Horellou MH; Samama M
    Lancet; 1980 May; 1(8177):1091. PubMed ID: 6103429
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe hepatotoxicity from Escherichia coli L-asparaginase.
    Jenkins R; Perlin E
    J Natl Med Assoc; 1987 Jul; 79(7):775, 779. PubMed ID: 3305969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
    Aur RJ; Simone JV; Pratt CB
    Cancer; 1971 Jun; 27(6):1332-6. PubMed ID: 5282619
    [No Abstract]   [Full Text] [Related]  

  • 34. Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia.
    Pui CH; Chesney CM; Weed J; Jackson CW
    J Clin Oncol; 1985 Sep; 3(9):1266-72. PubMed ID: 3875694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Apropos of certain toxic effects of L-asparaginase in human therapy].
    Oberling F; Cazenave JP; Lang JM; Kurtz D; Mayer G; Waitz R
    Sem Hop; 1971 May; 47(22):1421-5. PubMed ID: 4326093
    [No Abstract]   [Full Text] [Related]  

  • 36. Glucose metabolism in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
    Pastore G; Saracco P; Brach del Prever A; Iannacci L; Miniero R; Madon E
    Acta Haematol; 1984; 72(6):384-7. PubMed ID: 6442522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
    Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 39. Serial sonograms to detect pancreatitis in children receiving L-asparaginase.
    Nguyen DL; Wilson DA; Engelman ED; Sexauer CL; Nitschke R
    South Med J; 1987 Sep; 80(9):1133-6. PubMed ID: 3306944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation in children of the clinical, biological and electroencephalographic side effects of L-asparaginase].
    Olive D; Cartault F; Legras B; Neimann N
    Pediatrie; 1976 Apr; 31(3):259-78. PubMed ID: 1069234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.